MGIM
JAZZ icon

M&G Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

M&G Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,061
Closed -$3.04K – 763
2021
Q2 		$3.04K Buy
+17,061
New +$2.96M 0.01% 468

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

M&G Investment Management's JAZZ Position: Q3 2021 in Review

M&G Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 17,061 shares — an estimated $3.04K sold.

M&G Investment Management first reported a position in JAZZ in Q2 2021 and held it in 1 quarter. The position peaked at $3.04K in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • M&G Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • M&G Investment Management sold 17,061 Jazz Pharmaceuticals shares in Q3 2021, an estimated $3.04K.
  • M&G Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • M&G Investment Management's Jazz Pharmaceuticals position peaked at $3.04K in Q2 2021.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on M&G Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.